Table 9
Number of Patients Referenced in FDA NDA

. Industry only sponsored Government sponsored
or co-sponsored		   Total  
Nucleoside Analogue Reverse
Transcriptase Inhibitors (NARTI)		 409 850 1,259
Protease Inhibitors (PI) 1,050 59 1,109
Non-Nucleoside Reverse
Transciptase Inhibitors (NNRTI)		 930 380 1,310
Mean, 14 drugs 750 466 1,216

Nucleoside Analogue Reverse Transcriptase Prohibitors (RT)

.     Total     Sponsored/cosponsored
by government
Zidovudine (AZT) 282 0
Didanosine (ddI) 1,530 1,530
Zalcitabine (ddC) 3,569 3,569
Stavudine (d4T 822 0
Lamivudine (3TC) 972 don't know
Abacavir 378 0

Protease Inhibitors

. Total     Sponsored/cosponsored
by government
Saquinavir 1,357 295
Ritonavir 1,583 0
Indinavir 1,262 0
Nelfinavir 605 0
Amprenavir 736 0

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)

. Total Sponsored/cosponsored
by government.
Nevirapine 549 398
Delavirdine 2,452 544
Efavirenz 928 196

Source: Number of patients in trials cited by FDA in approval of 14 HIV/AIDS drugs. Version 1.1, CPTech.org. September 21, 2000.

CPT Home IP and Healthcare CPT page on South Africa James Love's Affidavit